Kozaki, R.; Vogler, M.; Walter, H.S.; Jayne, S.; Dinsdale, D.; Siebert, R.; Dyer, M.J.S.; Yoshizawa, T.
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines. Cancers 2018, 10, 127.
https://doi.org/10.3390/cancers10040127
AMA Style
Kozaki R, Vogler M, Walter HS, Jayne S, Dinsdale D, Siebert R, Dyer MJS, Yoshizawa T.
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines. Cancers. 2018; 10(4):127.
https://doi.org/10.3390/cancers10040127
Chicago/Turabian Style
Kozaki, Ryohei, Meike Vogler, Harriet S. Walter, Sandrine Jayne, David Dinsdale, Reiner Siebert, Martin J.S. Dyer, and Toshio Yoshizawa.
2018. "Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines" Cancers 10, no. 4: 127.
https://doi.org/10.3390/cancers10040127
APA Style
Kozaki, R., Vogler, M., Walter, H. S., Jayne, S., Dinsdale, D., Siebert, R., Dyer, M. J. S., & Yoshizawa, T.
(2018). Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines. Cancers, 10(4), 127.
https://doi.org/10.3390/cancers10040127